US 11,806,492 B2
Trans middle ear-inner ear fluid flow implementations
Kenneth Oplinger, Macquarie University (AU); Tommy Bergs, Macquarie University (AU); and Soren Nilsson, Macquarie University (AU)
Assigned to Cochlear Limited, Macquarie University (AU)
Appl. No. 16/649,757
Filed by COCHLEAR LIMITED, Macquarie University (AU)
PCT Filed Sep. 21, 2018, PCT No. PCT/IB2018/057325
§ 371(c)(1), (2) Date Mar. 23, 2020,
PCT Pub. No. WO2019/058330, PCT Pub. Date Mar. 28, 2019.
Claims priority of provisional application 62/561,985, filed on Sep. 22, 2017.
Prior Publication US 2020/0238062 A1, Jul. 30, 2020
Int. Cl. A61M 31/00 (2006.01); H04R 25/00 (2006.01)
CPC A61M 31/00 (2013.01) [H04R 25/558 (2013.01); H04R 25/606 (2013.01); A61M 2205/05 (2013.01); A61M 2210/0668 (2013.01); H04R 2460/13 (2013.01)] 29 Claims
OG exemplary drawing
 
1. A prosthesis, comprising:
an apparatus configured to deliver a therapeutic substance from outside a cochlea to inside the cochlea and configured to evoke a mechanically based hearing percept, wherein
at least one of:
the apparatus is configured to be controlled to evoke the mechanically based hearing percept without delivering the therapeutic substance from outside the cochlea to inside the cochlea; or
the apparatus is configured to be controlled to deliver the therapeutic substance from outside the cochlea to inside the cochlea without evoking the mechanically based hearing percept.